Quadrivalent Influenza Vaccine (split virion, inactivated) is indicated for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine for active immunisation of adults, including pregnant women, and children from 6 months of age and older, and for passive protection of infants from birth to less than 6 months of age following vaccination of pregnant women.
Quadrivalent Influenza vaccine (split virion, inactivated) is available in single doses and multipacks of 10 doses.
The use of Quadrivalent Influenza Vaccine (split virion, inactivated) should be based on official recommendations.
Before you prescribe this vaccine please refer to the Prescribing Information and SmPC
Date of preparation: May 2023